寶

02659

寶濟藥業-B

8.010

-0.415-4.93%
Closed16:08 10/30 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE8.475/8.070
TODAY RANGE8.310-10.900
VOL18.65M
MARKET CAP3.02B
52 WEEK RANGE6.475-206.000
AVG VOL (3M)875.24K
% TURNOVER5.69%
TURNOVER186.30M
P/E (TTM)-7.104
% RANGE32.09%
EPS(TTM)-1.304
P/E(FORWARD)--
P/B1.794
BVPS5.161
DIVIDEND--
P/S152.554
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.40B
SHARES OUTSTANDING325.98M
NEXT EARNINGS--
FREE FLOAT151.54M
LOT SIZE100
EX-DATE--
Same Industry
Name/Symbol
Change%
Price

昊

昊海生物科技

06826

-2.68%
15.630

藥

藥明康德

02359

-2.98%
185.400

泰

泰格醫藥

03347

-0.21%
37.920

J

JOINN Laboratories (China)

06127

-1.55%
22.880

P

Pharmaron Beijing

03759

+0.22%
26.980

方

方達控股

01521

0.00%
1.490

01035

--

中

中國醫療集團

08225

0.00%
0.066

M

Mingyuan Medicare Development

00233

0.00%
0.230

08572

--

M

Mabpharm

02181

0.00%
0.435

維

維亞生物

01873

-1.96%
1.250

中

中國再生醫學

08158

-0.41%
0.245

B

BioDlink International

01875

-0.45%
3.310

華

華領醫藥-B

02552

-3.76%
2.175

微

微創腦科學

02172

0.00%
8.055

康

康寧傑瑞製藥-B

09966

-4.24%
6.215

中

中國抗體-B

03681

+4.90%
1.070

L

Lepu Biopharma

02157

+2.94%
3.155

J

Jacobio Pharmaceuticals Group

01167

-0.65%
4.600

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.